Navigation Links
Tengion Announces Addition of Two Renal Experts to Research & Development Advisors Panel
Date:3/23/2011

National Kidney Foundation Young Investigator Award and the American Society of Nephrology Gottschalk Research Scholar Award. He investigates kidney repair in order to translate this knowledge into therapies for patients with kidney disease.

The Neo-Kidney Augment is Tengion's lead preclinical program and is intended to prevent or delay the need for dialysis or kidney transplant by increasing functional kidney mass in patients with advanced chronic kidney disease, a significant unmet medical need. Tengion has now published or presented consistently positive data on the effect of its approach on kidney function in four different animal models of chronic kidney disease, including in a canine model of kidney failure. By the end of 2011, Tengion intends to seek an initial regulatory interaction with FDA for the Neo-Kidney Augment program to clarify the path to clinical trials.

About Tengion

Tengion, a clinical-stage biotechnology company, has pioneered the Organ Regeneration Platform™ that enables the Company to create proprietary product candidates that are intended to harness the intrinsic regenerative pathways of the body to produce a range of native-like organs and tissues. Tengion's product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. An initial clinical trial is ongoing for the Company's lead product candidate, the Neo-Urinary Conduit™, an autologous implant that is intended to catalyze regeneration of native-like bladder tissue for bladder cancer patients requiring a urinary diversion following bladder removal.  The Company's lead preclinical program is the Neo-Kidney Augment™, which is designed to delay or prevent the need for dialysis or transplantation in patients at risk for kidney failure.  Tengion has also applied its technology in two Phase II clinical trial
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
2. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
3. Tengion Announces Second Closing of Series C Financing
4. Tengion to Present at the Piper Jaffray 20th Annual Healthcare Conference
5. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
6. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
7. Tengion Appoints A. Brian Davis Chief Financial Officer
8. Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010
9. Tengion Appoints Richard E. Kuntz, MD to its Board of Directors
10. Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference
11. Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Communications, a leading provider of strategic communications services to corporations and ... the United States and Europe ... JD, is returning to the firm,s Washington, D.C. ... more than two years of service as Associate Commissioner for the ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
(Date:1/14/2014)... and BETHESDA, Md. , ... joining together with two institutes from the National Institutes ... tools for bringing safer, more effective treatments to patients ... National Center for Advancing Translational Sciences (NCATS) and the ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... In Vitro and In Vivo Data Show AEZS-126 as ... CancerQUEBEC CITY, April 21 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. ... biopharmaceutical company focused on endocrine therapy and oncology, today ... clinical intervention of the PI3K/ Akt pathway in human ...
... HUBBARD, Ohio, April 21 NanoLogix, Inc. (OTC: NNLX) ... square foot manufacturing facility at its headquarters in Hubbard, ... vault, and shipping and receiving area to be used ... revolutionary new BNP(TM) kits provide accelerated detection of bacteria ...
... Data Selected for Presentation Highlights Anti-Tumor effects of ... Inc. (Nasdaq: KERX ) today announced ... effects of KRX-0401 (perifosine), the company,s lead anti-cancer ... (AACR) Annual Meeting, being held in Denver, Colorado. ...
Cached Biology Technology:AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting 2AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting 3NanoLogix Begins Construction of Production Facility for Medical Test Kits 2NanoLogix Begins Construction of Production Facility for Medical Test Kits 3Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research 2Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research 3Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research 4
(Date:4/22/2014)... new secret to get your child to behave at the ... new Cornell study published in Eating Behaviors , found ... to bite with their front teeth such as drumsticks, whole ... than when these foods had been cut. "They were ... toward other kids," said Brian Wansink, Professor and Director of ...
(Date:4/22/2014)... from the Florida campus of The Scripps Research Institute ... critical but previously unknown role in learning and memory ... role for a protein known as RGS7, was published ... a publisher supported by the Howard Hughes Medical Institute, ... "This is a critical building block that regulates a ...
(Date:4/22/2014)... Scientists at the University of Massachusetts Amherst and the ... week report that they have discovered a new genus ... the Negro River in the Amazonia State of Brazil. ... Adlia Nogueira and Jos Antnio Alves-Gomes of INPA, describe ... the journal Proceedings of the Natural Sciences of ...
Breaking Biology News(10 mins):Biting vs. chewing 2Scientists identify critical new protein complex involved in learning and memory 2New electric fish genus and species discovered in Brazil's Rio Negro 2
... Yang Wang is known for conducting complex research using highly ... spent days hiking through the remote outback of Tibet and ... the name of scientific discovery. Because of that unique ... a team of researchers that uncovered the oldest prehistoric woolly ...
... found in the oceans and belong to the group SAR11. ... an explanation for their success and at the same time ... their analysis they have also identified a rare and hitherto ... findings were published in two articles in the journals ...
... D.C. The American Association for Cancer Research will ... Cancer Health Disparities from Sept. 18-21, 2011, in the ... This conference will bring together scientists, survivors, doctors and ... epidemiology and treatment methods to better meet the needs ...
Cached Biology News:A wild and woolly discovery: FSU scientist's Tibetan expedition ends with prehistoric find 2A wild and woolly discovery: FSU scientist's Tibetan expedition ends with prehistoric find 3Unknown ocean bacteria create entirely new theories 2AACR to host conference on the science of cancer health disparities 2
...
... The Thermo Labsystems Wellmix is a high-quality ... time settings. The shaking speed is adjustable ... frequency, high speed and a small orbit ... The shaking time is quick and easy ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... together two mature, well-understood technologies: grating-based ... This combination produces a sensitive and ... of molecular binding events without the ... capture molecules are immobilized on the ...
Biology Products: